Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Compressed Air in Pharma Industry in 2026 Down to the Last Point of Use

How clean is the compressed air reaching your pharmaceutical products? Explore GMP requirements, ISO purity classes, contamination risks, and qualification practices. Learn how to monitor air quality, prevent failures, and maintain compliance at every point of use.
  • Blog, Validation and Qualification
Pharmaceutical compressed air system with stainless steel piping, air filtration units, a cleanroom technician, and a point of use sterile filter supplying an aseptic vial filling line.

Pharmaceutical Clean Steam in 2026 Judged by What Its Condensate Proves

Can your clean steam system withstand a GMP inspection? Discover how condensate testing, chemical purity, endotoxin control, and steam performance checks reveal hidden risks. Learn what inspectors expect and how to build reliable evidence for compliance.
  • Blog, Validation and Qualification
Pharmaceutical pure steam condensate sampling from a stainless-steel system, illustrating steam quality testing, analytical monitoring, and contamination control.

WFI vs Purified Water in 2026 Where One Endotoxin Limit Draws the Line

Your water system can pass conductivity checks and still be unsuitable for injectable manufacturing. Discover how the 0.25 EU/mL endotoxin limit separates WFI from Purified Water, what inspectors check in distribution loops, and which grade each process step requires.
  • Blog, Validation and Qualification
Pharmaceutical water system showing stainless steel distribution loops, conductivity and total organic carbon monitoring, and water for injection used in sterile manufacturing.

Pharmaceutical Water System in 2026 and What Inspectors Check from PW to WFI

What do GMP inspectors really check in pharmaceutical water systems? Explore critical PW and WFI requirements, validation gaps, microbial risks, and recurring FDA findings. Discover practical inspection checkpoints and strategies to maintain compliance and protect product quality.
  • Blog, Validation and Qualification
Pharmaceutical engineer inspecting a purified water system with stainless steel tanks, distribution piping, and digital monitoring of total organic carbon and water quality.

Pharmaceutical Utilities in 2026 for GMP Water, Steam, HVAC, and Process Gases

From water for injection to clean steam, HVAC, and process gases, pharmaceutical utilities carry hidden GMP risks. Explore what inspectors examine, how systems are qualified, and which monitoring controls maintain compliance throughout the manufacturing lifecycle.
  • Blog, Validation and Qualification
GMP engineer inspecting a pharmaceutical water system, clean steam piping, HVAC airflow, and process gas distribution in a modern pharmaceutical manufacturing facility.

Pharmaceutical Engineering in 2026 and Its Role Across the GMP Lifecycle

From early facility decisions to requalification, small engineering gaps can become costly GMP findings. Explore how risk-based design, commissioning, equipment qualification, maintenance, and change control build inspection-ready systems—and what regulators expect to see in the supporting records.
  • Blog, Validation and Qualification
Pharmaceutical engineer using a tablet beside stainless-steel processing equipment in a GMP cleanroom, with digital equipment qualification diagrams and lifecycle monitoring graphics.

Pharma Consultancy in Indore in 2026 for USFDA and Schedule M Compliance

What does it take to satisfy two regulatory frameworks with one quality system? Explore how pharma consultancy in Indore helps Pithampur manufacturers address USFDA scrutiny, revised Schedule M, validation gaps, and data integrity risks before inspections begin.
  • Blog, Quality Management System
Pharmaceutical scientist working in a QC laboratory beside a cleanroom production line, with USFDA and Indian compliance shields illustrating data integrity and regulatory inspection readiness.

Pharma Consulting Companies in India in 2026: GMP, Regulatory, Validation and Market Access Guide

Indian drug regulators have inspected over 1,040 sites, and Revised Schedule M now makes WHO-aligned GMP the legal baseline. Learn how to judge pharma consulting companies in India by what still holds when the inspector walks in.
  • Blog, Quality Management System
GMP consultants in India reviewing pharmaceutical manufacturing compliance, quality systems, validation records, and inspection readiness.

FDA IVD Guidance in 2026: What FDA Expects From 510(k) to QMSR Inspections

Since QMSR took effect in February 2026, FDA inspectors can review internal audits and management reviews. Learn what FDA IVD guidance expects, from 510(k) pathways and analytical validation to labeling, LDT status and the Form 483 gaps investigators cite most.
  • Blog, Medical Devices
FDA IVD regulation lifecycle showing in vitro diagnostic devices, analytical validation, clinical performance testing, 510(k) submission, and QMSR inspection.

IVD Regulations in 2026: EU IVDR, FDA Requirements, Performance Evaluation and Global Compliance

IVD regulations now decide market access in both the EU and US. Learn how notified bodies test classification, performance evaluation and transition status, where IVDR and FDA requirements differ, and which compliance gaps auditors’ flag most often.
  • Blog, Medical Devices
Modern diagnostic laboratory showing IVD testing equipment, regulatory documentation, and EU-US market access under IVDR and FDA requirements.